CMV antigenemia, viremia, and disease in CMV high-risk patients.

The probabilities of CMV antigenemia (panel A), CMV viremia (panel B), and CMV disease (panel C) are displayed. The probability for CMV disease was analyzed for the first year after transplantation; for other events, the analyses were done for the first 100 days after transplantation.